An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC

Published:2023-02 Issue: Volume:Volume 15 Page:101-119
ISSN:1179-1314
Container-title:Breast Cancer: Targets and Therapy
language:en
Short-container-title:BCTT

Author:

Zhang Mengqi^ORCID,Bao Shengxian^ORCID,Qiu Guanhua,Liang Jingchen^ORCID,Wang Qin,Zhu Xiaoqi,Qin Guchun,Liu Junjie,Zhao Chang

Publisher

Informa UK Limited

Subject

Oncology

Reference52 articles.

1. Cancer nanotechnology: opportunities and challenges

2. Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer

3. Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies

4. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells

5. Doxorubicin pathways

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of mesoporous magnetic nanoparticles supported idarubicin and investigation of apoptotic and cytotoxic effects on cancer cell lines;Molecular Biology Reports;2024-09-11

2. Au-Fe3O4 Janus nanoparticles for imaging-guided near infrared-enhanced ferroptosis therapy in triple negative breast cancer;Journal of Colloid and Interface Science;2024-06

3. Recent Developments in Combination Immunotherapy with Other Therapies and Nanoparticle-Based Therapy for Triple-Negative Breast Cancer (TNBC);Cancers;2024-05-25

4. Unveiling innovative therapeutic strategies and future trajectories on stimuli-responsive drug delivery systems for targeted treatment of breast carcinoma;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-14

5. Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer;Biomedicine & Pharmacotherapy;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3